CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

NATIXIS ADVISORS, L.P.'s Holding History (CIK: 0001018331)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 20,035 Value ($000) $1 Avg Close $44.52 Range $38.81 - $50.98
Q3 2025
Shares 51,746 Value ($000) $2 Avg Close $31.97 Range $25.83 - $47.41
Q2 2025
Shares 47,115 Value ($000) $1 Avg Close $30.88 Range $24.10 - $34.68
Q1 2025
Shares 46,509 Value ($000) $2 Avg Close $37.35 Range $31.65 - $53.55
Q4 2024
Shares 45,683 Value ($000) $2 Avg Close $55.95 Range $49.48 - $62.53
Q3 2024
Shares 44,346 Value ($000) $2 Avg Close $51.57 Range $43.71 - $55.78
Q2 2024
Shares 32,476 Value ($000) $1 Avg Close $46.18 Range $41.01 - $53.70
Q1 2024
Shares 27,424 Value ($000) $1 Avg Close $39.13 Range $33.67 - $47.58
Q4 2023
Shares 25,541 Value ($000) $1 Avg Close $30.67 Range $25.35 - $37.88
Q3 2023
Shares 25,630 Value ($000) $1 Avg Close $20.61 Range $15.76 - $31.00
Q2 2023
Shares 20,387 Value ($000) $0 Avg Close $19.94 Range $15.50 - $24.58
Q1 2023
Shares 20,222 Value ($000) $0 Avg Close $18.51 Range $15.23 - $21.65
Q4 2022
Shares 11,764 Value ($000) $0 Avg Close $17.62 Range $15.37 - $19.97
Q3 2022
Shares 11,848 Value ($000) $233 Avg Close $20.39 Range $17.79 - $22.85
Q2 2022
Shares 11,877 Value ($000) $222 Avg Close $19.96 Range $15.91 - $27.86